Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
26.57
+0.21 (0.80%)
Dec 5, 2025, 4:00 PM EST - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Pelthos Therapeutics stock have an average target of 56, with a low estimate of 50 and a high estimate of 60. The average target predicts an increase of 110.76% from the current stock price of 26.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pelthos Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 3 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +88.18% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +125.82% | Dec 3, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +114.53% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $57 | Buy | Reiterates | $50 → $57 | +114.53% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +88.18% | Sep 2, 2025 |
Financial Forecast
Revenue This Year
12.66M
Revenue Next Year
46.26M
from 12.66M
Increased by 265.40%
EPS This Year
-17.19
from -14.27
EPS Next Year
-4.91
from -17.19
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 20.8M | 76.5M | ||||
| Avg | 12.7M | 46.3M | ||||
| Low | 5.5M | 26.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 504.5% | ||||
| Avg | - | 265.4% | ||||
| Low | - | 105.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -15.42 | -0.58 | ||||
| Avg | -17.19 | -4.91 | ||||
| Low | -18.63 | -11.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.